Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Massimo Lemoli

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Leukemia Research|May 28, 2015
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromesPaola Minetto, Fabio Guolo, Marino Clavio, et al.
PEC Innovation|October 27, 2025
The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphomaFabio Guolo, Francesca Riccardi, Paola Del Sette, et al.
Journal of Clinical Medicine|September 28, 2023
Harnessing Immune Response in Acute Myeloid LeukemiaCarola Riva, Chiara Vernarecci, Paola Minetto, et al.
Leukemia & Lymphoma|September 5, 2019
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomasLorenzo Manconi, Elisa Coviello, Filippo Canale, et al.
Cancers|March 13, 2025
Prognostic Frailty-Based Determinants of Long-Term Mortality in Older Patients with Newly Diagnosed Multiple MyelomaMariya Muzyka, Silvia Ottaviani, Irene Caffa, et al.
Cancers|December 1, 2020
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate LymphocytesSilvia Pesce, Sara Trabanelli, Clara Di Vito, et al.
Oncotarget|May 19, 2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patientsMaria Rosaria Ricciardi, Valentina Salvestrini, Roberto Licchetta, et al.
American Journal of Hematology|April 17, 2016
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patientsFabio Guolo, Paola Minetto, Marino Clavio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 5, 2014
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective studyMassimo Martino, Mauro Montanari, Felicetto Ferrara, et al.
Cytotherapy|September 18, 2017
Molecular and functional characterization of CD133<sup>+</sup> stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cellsLucia Catani, Daria Sollazzo, Elisa Bianchi, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Leukemia Research|May 28, 2015
Combined assessment of WT1 and BAALC gene expression at diagnosis may improve leukemia-free survival prediction in patients with myelodysplastic syndromesPaola Minetto, Fabio Guolo, Marino Clavio, et al.
PEC Innovation|October 27, 2025
The protective role of HCWs communication for the distress of newly diagnosed people with leukemia and lymphomaFabio Guolo, Francesca Riccardi, Paola Del Sette, et al.
Journal of Clinical Medicine|September 28, 2023
Harnessing Immune Response in Acute Myeloid LeukemiaCarola Riva, Chiara Vernarecci, Paola Minetto, et al.
Leukemia & Lymphoma|September 5, 2019
Dexamethasone, oxaliplatin and cytarabine (R-DHAOx) as salvage and stem cells mobilizing therapy in relapsed/refractory diffuse large B cell lymphomasLorenzo Manconi, Elisa Coviello, Filippo Canale, et al.
Cancers|March 13, 2025
Prognostic Frailty-Based Determinants of Long-Term Mortality in Older Patients with Newly Diagnosed Multiple MyelomaMariya Muzyka, Silvia Ottaviani, Irene Caffa, et al.
Cancers|December 1, 2020
Cancer Immunotherapy by Blocking Immune Checkpoints on Innate LymphocytesSilvia Pesce, Sara Trabanelli, Clara Di Vito, et al.
Oncotarget|May 19, 2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patientsMaria Rosaria Ricciardi, Valentina Salvestrini, Roberto Licchetta, et al.
American Journal of Hematology|April 17, 2016
High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patientsFabio Guolo, Paola Minetto, Marino Clavio, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|April 5, 2014
Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective studyMassimo Martino, Mauro Montanari, Felicetto Ferrara, et al.
Cytotherapy|September 18, 2017
Molecular and functional characterization of CD133<sup>+</sup> stem/progenitor cells infused in patients with end-stage liver disease reveals their interplay with stromal liver cellsLucia Catani, Daria Sollazzo, Elisa Bianchi, et al.
Pageof 5